Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Fabrinet financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$252.4
2024-10-29
Market Capitalization
$9.2 B
2024-10-29
Revenue
$3.4 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 2.3B | 2.6B | 2.9B | 3.4B |
| Cost of goods sold | 2.0B | 2.3B | 2.5B | 3.0B |
| Gross profit | 278.6M | 336.3M | 356.1M | 413.3M |
| Gross profit margin, % | 12.3% | 12.7% | 12.4% | 12.1% |
| General and administrative expense | 73.9M | 77.7M | 78.5M | |
| Operating expense total | 74.1M | 84.6M | 78.5M | 88.9M |
| EBIT | 204.5M | 251.7M | 277.6M | 324.4M |
| EBIT margin, % | 9.0% | 9.5% | 9.6% | 9.5% |
| Interest income | 2.2M | 11.2M | 33.2M | 40.2M |
| Interest expense | 432.0K | 1.5M | 124.0K | |
| Pre tax profit | 207.0M | 260.1M | 311.4M | 355.2M |
| Income tax expense | 6.6M | 12.2M | 15.2M | 22.7M |
| Net Income | 200.4M | 247.9M | 296.2M | 332.5M |
| EPS | 5.4 | 6.7 | 8.1 | 9.2 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |